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GOVERNOR PATRICK CELEBRATES GRAND 
OPENING OF LABCENTRAL BIOTECH HUB, 
ANNOUNCES $5 MILLION IN CAPITAL FUNDING 
MLSC capital grant will double the size of LabCentral 
 
CAMBRIDGE – Tuesday, April 2, 2014 – Governor Deval Patrick today will join the 
Massachusetts Life Sciences Center (MLSC), MIT President Rafael Reif, LabCentral’s 
leadership, industry stakeholders and state and local officials to celebrate the grand 
opening of LabCentral’s state-of-the-art, 28,000 square-foot facility in Kendall Square in 
Cambridge. The Governor will also announce $5 million in additional capital funding 
from the MLSC for LabCentral to fund build-out of additional space of equal size near 
LabCentral’s existing 700 Main Street location, continuing the Patrick Administration’s 
dedication to expanding opportunities for innovative life sciences and biotech 
companies.  
  
“Almost one year ago today, I was pleased to take part in the groundbreaking event for 
LabCentral,” said Governor Patrick. “I spoke then about shaping our own future through 
the choices we make in public investment. The Massachusetts Life Sciences Center 
and an impressive array of sponsors decided to bet on LabCentral – precisely the kind 
of decision that can help make the economy stronger and grow opportunity in the 
Commonwealth. It’s a bet that’s paying off. Today, LabCentral is the embodiment of 
innovation and is nurturing the next generation of life-sciences companies that will grow 
jobs, grow ideas and grow solutions to improve health.” 
LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for 
high-potential life-sciences and biotech startups. Currently, LabCentral can house a 
maximum of 25 companies. The MLSC capital grant will enable LabCentral to become 
home to many more early-stage companies. LabCentral is a unique facility, founded on 
the open innovation model, which has revolutionized the tech environment. State-of-the-
art laboratory equipment is critical, but not enough. Life-sciences companies are more 
likely to develop quickly when they start out in a supportive environment that facilitates 
creative exchange of science and business ideas. LabCentral’s staff and partners 
anticipate residents’ needs and help eliminate roadblocks to growth. LabCentral’s open 
floor plan and inspired work, lab and play spaces foster collaboration and the sharing of 
best practices. Designed to benefit the entire Life Sciences community, LabCentral 
targets what is the most critical unmet need for Massachusetts Life Sciences 
entrepreneurs – to make it easier, or “lower the bar,” for scientists to start new, high-risk 
companies with transformational potential.  
Through the MLSC, Massachusetts is investing $1 billion over 10 years in the growth of 
the state’s life sciences ecosystem. These investments are being made under the 
Massachusetts Life Sciences Initiative, proposed by Governor Patrick in 2007, and 
passed by the Legislature and signed into law by Governor Patrick in 2008. To date the 
MLSC has awarded more than $370 million to support life sciences-related capital 
projects across the state, creating thousands of jobs and more than 1.3 million square 
feet of new education, research and manufacturing space. 
“We are thrilled to be an ongoing partner in LabCentral, a vital resource for the 
Commonwealth and indeed the world,” said Susan Windham-Bannister, Ph.D., 
President & CEO of the MLSC. “Our initial $5 million investment has helped LabCentral 
attract nearly three-times that in donations of cash, state-of-the-art equipment, and in-
kind services. LabCentral exemplifies one of the key strategies for the use of our capital 
dollars – the establishment of unique resources that are available to industry, and that 
will allow Massachusetts to further expand our global leadership in the life sciences. It’s 
clear that demand for LabCentral’s unique combination of shared lab space and expert 
services will fast outpace its current capacity, and we are pleased to be announcing 
today a second round of funding to support LabCentral’s expansion.” 
“What an exciting day for all of us,” said Dr. Johannes Fruehauf, founder of LabCentral. 
“Our goal has been to create a fertile environment where visionaries can thrive. It’s 
extraordinarily gratifying to see our vision of LabCentral come to fruition here at historic 
700 Main Street. We’ve been successful thanks to the generosity of our sponsors, the 
dedication of our employees and partners, and the creativity of our residents.” 
LabCentral has partnered with MIT to create its community space. One of Cambridge’s 
oldest industrial complexes, the building was renovated by the Institute to showcase its 
historic architecture and significant contributions to industry and manufacturing. From 
the first two-way long distance phone call to the invention of the Polaroid camera, the 
building is no stranger to innovation. A dozen startups are currently in residence at 
LabCentral, several of which are developing technologies out of MIT, and more 
companies are slated to move in over the next few months. 
  
A 28,000 square-foot facility in the heart of the Kendall Square, Cambridge, biotech 
innovation hub LabCentral is a first-of-its-kind shared laboratory space designed as a 
launchpad for high-potential Life Sciences and biotech startups. It offers fully permitted 
laboratory and office space for as many as 25 startups comprising approximately 100 
scientists and entrepreneurs. LabCentral provides first-class facility and administrative 
support, skilled laboratory personnel, a domain-relevant expert speaker series, as well 
as the other critical services and support that early-stage companies need to begin 
laboratory operations on day one. A private, nonprofit institution, LabCentral was funded 
in part by a $5 million grant from the Massachusetts Life Sciences Center, with support 
from its real-estate partner, MIT. Founding sponsors include Triumvirate Environmental 
and Johnson & Johnson Innovation. 
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